Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -13.51%21 Return-on-Tangible-Equity is -89.26% as of Dec. 2025. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 859 Media - Diversified companies, Haoxi Health Technology ranks worse than 81.61% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Haoxi Health Technology's annualized net income for the quarter that ended in Dec. 2025 was $-13.76 Mil. Haoxi Health Technology's average shareholder tangible equity for the quarter that ended in Dec. 2025 was $15.42 Mil. Therefore, Haoxi Health Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was -89.26%.
The historical rank and industry rank for Haoxi Health Technology's Return-on-Tangible-Equity or its related term are showing as below:
HAO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -17.48 Med: 234.73 Max: 1920.79
Current: -17.48
During the past 5 years, Haoxi Health Technology's highest Return-on-Tangible-Equity was 1,920.79%. The lowest was -17.48%. And the median was 234.73%.
HAO's Return-on-Tangible-Equity is ranked worse than 81.61% of 859
companies
in the Media - Diversified industry
Industry Median: 5.19
vs HAO: -17.48
Haoxi Health Technology (NAS:HAO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Haoxi Health Technology Return-on-Tangible-Equity Related Terms
Haoxi Health Technology Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Haoxi Health Technology's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology Return-on-Tangible-Equity Chart
HAO vs BAOS, DBMM, DRCT: Return-on-Tangible-Equity Comparison
For the Advertising Agencies subindustry, Haoxi Health Technology's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haoxi Health Technology Return-on-Tangible-Equity vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Haoxi Health Technology's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -89.26% mean?
Haoxi Health Technology (HAO) has a Return-on-Tangible-Equity of -89.26% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Haoxi Health Technology and its competitors. According to the industry distribution chart, Haoxi Health Technology ranks #701 out of 859 companies in the Media - Diversified industry, placing it in the top 81.6%.
Is Haoxi Health Technology's Return-on-Tangible-Equity too high?
Haoxi Health Technology's current Return-on-Tangible-Equity is -89.26%. Based on the distribution chart, Haoxi Health Technology ranks #701 out of 859 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's Return-on-Tangible-Equity compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #701 out of 859 companies for Return-on-Tangible-Equity. This places Haoxi Health Technology in the lower half of its industry. The industry median Return-on-Tangible-Equity is 5.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Media - Diversified company?
The median Return-on-Tangible-Equity among Media - Diversified companies is 5.19, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Haoxi Health Technology and its competitors. For the Media - Diversified industry, the median Return-on-Tangible-Equity is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current Return-on-Tangible-Equity is -89.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current Return-on-Tangible-Equity of -89.26%. The current Return-on-Tangible-Equity is -89.26%. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current Return-on-Tangible-Equity is -89.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
